Abstract
Introduction
Giant cell glioblastoma is a subtype of glioblastoma multiforme (GM) whose most characteristic histology is the presence of plentiful multinucleated giant cells. These tumours are very rare and account for only 5% of GM. They do not have specific localization, although normally they are supratentorial and affect mostly the temporal lobe. They may occur at any age, but mostly they occur in younger people than GM. They are infrequent in childhood, but they have longer survival in paediatric age.
Case report
We present an 11-year-old girl that was operated but whose tumour recurred in a month after apparent total removal.
Discussion
We review in the literature the clinical, histological, immuno-histochemical and genetic characteristics, as well the prognosis of this tumour.
Similar content being viewed by others
References
Artico M, Cervoni L, Celli P, Salvati M, Palma L (1993) Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst 9:7–9
Burger PC, Vollmer RT (1980) Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 46:1179–1186
Campbell JW, Pollack IF, Martínez AJ, Shultz B (1996) High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38:258–264
Chandler KL, Prados MD, Malec M, Wilson CB (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32:716–720
Giannini C, Scheithauer B, Burger C, Brat D, Wollan P, Lach R, O’Neill P (1999) Pleomorphic xanthoastrocytoma. What do we really know about it? Cancer 85:2033–2045
Margetts JC, Kalyan-Raman UP (1989) Giant-celled glioblastoma of brain. A clinico–pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer 63:524–531
Kato M, Aida T, Sugimoto S, Suwamura Y, Abe H, Isu T, Kaneko S, Mitsumori K, Kojima H, Nakamura N, Nagashima K (1995) Immunohistochemical analysis of giant cell glioblastoma. Pathol Int 45:275–282
Klein R, Mölenkamp G, Sörensen N, Roggendorf W (1998) Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs Nerv Syst 14:288–291
Macaulay RJ, Jay V, Hoffman HJ, Becker LE (1993) Increased mitotic activity as negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report. J Neurosurg 79:761–768
McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM (1998) Tumors of central neuroepithelial origin. In: Bigner DD, McLendon RE, Bruner JM (eds) Russell and Rubinstein’s pathology of tumors of the nervous system, 6th edn. Arnold, London, pp 307–571
Ohgaki H, Peraud A, Nakazato Y, Watanabe K, Von Deimling A (2000) Giant cell glioblastoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics. Tumor of the nervous system. IARC, Lyon, pp 40–41
Palma L, Celli P, Maleci A, Di Lorenzo N, Cantore G (1989 ) Malignant monstrocellular brain tumours. A study of 42 surgically treated cases. Acta Neurochir 97:17–25
Peraud A, Watanabe K, Plate, KH, Yasuhiro Yonekama Y, Kleihues P, Ohgaki H (1997) P53 mutations versus EGF receptor expression in giant cell glioblastomas. J Neuropathol Exp Neurol 56:1236–1241
Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H (1999) Genetic profile of the giant cell glioblastoma. Lab Invest 79:123–129
Pollack IF, Campbell JW, Hamilton RL, Martínez AJ, Bozik ME (1997) Proliferation index as predictor of prognosis in malignant gliomas of childhood. Cancer 79:849–856
Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates A, Boyett J, Finlay JL (2002) Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery 50:1238–1244
Raco A, Bristot R, Salvati M, Delfín R (1997) Malignant supratentorial astrocytoma of late childhood. Our experience with 25 cases. Childs Nerv Syst 13:341–344
Rodriguez-Pereira C, Súarez-Peñaranda JM, Vazquez-Salvado M, Sobrido MJ, Abraldes M, Barros F, Forteza J (2000) Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathology study. J Neurosurg Sci 44:203–210
Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb W (2000) Preferential inactivation of the p53 tumor suppressor pathway and lack of EFGR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 10:249–259
Zulch KJ (1986) Brain tumors. Their biology and pathology, 3rd edn. Springer, Berlin Heidelberg New York, pp 407–413
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Prada, I., Cordobés, F., Azorín, D. et al. Pediatric giant cell glioblastoma: a case report and review of the literature. Childs Nerv Syst 22, 285–289 (2006). https://doi.org/10.1007/s00381-005-1178-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-005-1178-5